Tanaka, Atsushi http://orcid.org/0000-0002-6358-5283
Funding for this research was provided by:
the Ministry of Health, Labor, and Welfare of Japan (JPMH20FC1023)
Article History
Accepted: 9 November 2023
First Online: 12 December 2023
Declarations
:
: This work was supported by a Health and Labor Sciences Research Grant (research on intractable hepatobiliary disease) issued by the Ministry of Health, Labor, and Welfare of Japan (Grant Number JPMH20FC1023). The sponsor had no role in the study.
: Dr. A. Tanaka reports receiving consultant fees from EA Pharma, GlaxoSmithKline, Kowa Company Ltd., and Gilead Sciences.
: Not applicable.
: Not applicable.
: Not applicable.
: AT is the sole author of this manuscript
: Not applicable.
: Not applicable.
: Not applicable.